Drug Testing | Addiction Professional Magazine Skip to content Skip to navigation

Drug Testing

States eye adding gabapentin to controlled substance list

November 22, 2017  |  Rachael Zimlich, RN, Contributing Writer
Reports of increasing misuse of gabapentin, usually in combination with opioids or other drugs, have caught the attention of a number of state regulators.

Research seeks deeper understanding of how cocaine influences HIV

October 9, 2017  |  Gary A. Enos, Editor
A five-year research project could lead to more effective biomarkers for cocaine use and new therapeutic strategies for users with or without HIV.

Nearly all Ohio overdose deaths in early 2017 involved fentanyl

September 1, 2017  |  Gary A. Enos, Editor
A study found that fentanyl and its analogs were detected in more than 90% of the fatal overdoses in 24 Ohio counties in the first two months of this year.

Workers' compensation data shows slowing of long-term opioid prescribing

August 4, 2017  |  Gary A. Enos, Editor
Newly released data suggest that in a number of states, fewer injured workers are receiving long-term prescriptions for opioids.

Massachusetts case complicates decision-making on workplace marijuana testing

August 1, 2017  |  Gary A. Enos, Editor
The business community nationally is closely watching a Massachusetts case in which the state's highest court has affirmed an employee's right to use marijuana for medical purposes.

Some doctors pursuing genetic clues to medication response or misuse

September 1, 2016  |  Gary A. Enos, Editor
Predictive testing to evaluate the potential risks and benefits of opioids and other medications appears to have wide applicability in many sectors of healthcare.

Significant prevalence of gabapentin misuse seen in pain patients

August 5, 2016  |  Gary A. Enos, Editor
Data presented this week at a national scientific meeting indicate that a significant number of prescription opioid users are misusing the anti-seizure medication gabapentin.

Testing company launches trial in screening for genetic variables in drug response

July 22, 2016  |  Gary A. Enos, Editor
InSource Diagnostics is recruiting patients for a study employing urine testing to help determine which patients have a genetic mutation affecting response to drugs such as opioids.

Companies struggle to interpret marijuana test results

June 24, 2016  |  Alison Knopf, Contributing Writer
The inability of conventional drug testing to evaluate marijuana impairment creates uncertainty in the workplace testing environment.

Texas still poised to drug-test unemployment seekers

March 24, 2016  |  Gary A. Enos, Editor
A lengthy wait for federal guidance does not appear to have deterred Texas leaders in pursuing plans for drug testing of some applicants for unemployment benefits.

Some nightclub and festival goers are unwittingly exposed to bath salts

February 22, 2016  |  Gary A. Enos, Editor
Research based on hair samples taken from young adults attending nightclubs or dance festivals has found significant exposure to synthetic cathinones among individuals using Ecstasy/Molly.

Findings document difficulty of determining marijuana-related impairment

January 28, 2016  |  Gary A. Enos, Editor
Tests performed on adults before, during and after driving in a simulator illustrate the challenge of using blood THC concentration data to evaluate impairment while driving.


Subscribe to Drug Testing